[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356904-105":59,"doc-detail-356904-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","therapeutic-strategies-targeting-the-tumor-stromal-microenvironment-in-colorectal-cancer-a-narrative-review","Therapeutic Strategies Targeting the Tumor - Stromal Microenvironment in Colorectal Cancer - A Narrative Review","","Despite advances in colorectal cancer (CRC) treatment, outcomes in advanced disease remain poor. Current therapies largely target the epithelial compartment, while accumulating evidence identifies the tumor microenvironment (TME)—especially tumor stroma—as prognostic and potentially predictive. This narrative review synthesizes evidence on stromal features as biomarkers and therapeutic targets, including fibroblast-associated protein (FAP). Although stromal markers correlate with adverse outcomes, direct stromal-targeted therapies have largely not improved survival as single agents. Combination and biomarker-guided approaches may better address TME-driven resistance.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/therapeutic-strategies-targeting-the-tumor-stromal-microenvironment-in-colorectal-cancer-a-narrative-review/356904/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/therapeutic-strategies-targeting-the-tumor-stromal-microenvironment-in-colorectal-cancer-a-narrative-review/356904.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why does this review focus on the tumor stroma in colorectal cancer?","Question",{"text":113,"@type":114},"Outcomes in advanced CRC remain poor, and evidence indicates the tumor microenvironment—particularly the tumor stroma—strongly influences prognosis and treatment response.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What are stromal biomarkers, and how are they clinically relevant in CRC?",{"text":118,"@type":114},"The review summarizes stromal features used as biomarkers; for example, fibroblast-associated protein (FAP) is linked to adverse outcomes, supporting clinical relevance.",{"name":120,"@type":111,"acceptedAnswer":121},"Why have therapies targeting stromal components not worked well as single agents?",{"text":122,"@type":114},"Despite biomarker associations, therapies directly targeting stromal components have largely failed to improve survival when used alone, suggesting the need for more integrated strategies.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356904,1790221937,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Targeted Oncology (2026) 21:357–372  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1523-026-01220-5  \nTherapeutic Strategies Targeting the Tumor–Stromal Microenvironment in Colorectal Cancer: A Narrative Review  \nFloor Heilijgers1 · Marie‑Christine Bakker2 · Bente van Hest1 · Ingrid Franken2 · Frank M. Speetjens3 ·  \nKoen C. M. J. Peeters1 · Jeanine Roodhart2 · Wilma E. Mesker1  \nReceived: 27 December 2025 / Accepted: 13 April 2026 / Published online: 27 April 2026 © The Author(s) 2026  \nAbstract  \nDespite advances in colorectal cancer (CRC) treatment, outcomes in advanced disease remain poor. Current therapies mainly target the epithelial compartment of the tumor, yet increasing evidence highlights the tumor microenvironment (TME), particularly the tumor stroma, as a prognostic and potentially predictive factor. This narrative review summarizes current evidence on stromal features as biomarkers and therapeutic targets in CRC. These stromal markers, such as fibroblastassociated protein (FAP), are associated with adverse outcomes, underscoring their clinical relevance. However, therapies directly targeting these stromal components have largely failed to improve survival as single agents. Combination strategies, stromal modulation integrated with established treatments, appear more promising. However, to date, stromal targeting remains challenging and has not led to standard-of-care treatment options. This highlights the need for more effective agents, the rational design of combination strategies, and improved patient selection. Combining stroma modulators with standard therapy, guided by stromal biomarkers, may enhance efficacy and help overcome the TME-induced resistance.  \n* Wilma E. Mesker [w.e.mesker@lumc.nl](w.e.mesker@lumc.nl)  \nFloor Heilijgers  \n[f.heilijgers@lumc.nl](f.heilijgers@lumc.nl)  \nMarie-Christine Bakker  \n[m.e.bakker-48@umcutrecht.nl](m.e.bakker-48@umcutrecht.nl)  \nBente van Hest  \n[b.c.j.van_hest@lumc.nl](b.c.j.van_hest@lumc.nl)  \nIngrid Franken  \n[i.a.franken-4@umcutrecht.nl](i.a.franken-4@umcutrecht.nl)  \nFrank M. Speetjens  \n[f.m.speetjens@lumc.nl](f.m.speetjens@lumc.nl)  \nKoen C. M. J. Peeters  \n[k.c.m.j.peeters@lumc.nl](k.c.m.j.peeters@lumc.nl)  \nJeanine Roodhart  \n[j.roodhart@umcutrecht.nl](j.roodhart@umcutrecht.nl)  \n1 Department of Surgery, Leiden University Medical Center, Formal address: Albinusdreef 1, 2333 ZA Leiden, Postal address: Postbus 9600, 2300 RC Leiden, The Netherlands  \n2 Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands  \n3 Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands  \n1 Background  \nColorectal cancer (CRC) is the third most common cancer and the second-leading cause of cancer-related mortality worldwide [1] . CRC represents a biologically heterogeneous disease characterized by substantial inter-and intratumoral variability. This heterogeneity is reflected in distinct molecular pathways, which have important implications for prognosis and treatment response. Clinically, CRC is often  \nstratified according to microsatellite stability status, distinguishing microsatellite-stable (MSS) tumors from those with microsatellite instability (MSI), the latter typically associated with high immunogenicity and improved response to immune checkpoint inhibitors [2, 3] . In addition, mutational profiling has become central to therapeutic decision-making, with RAS and BRAF mutations defining major subgroups that exhibit greater chemoresistance and worse prognosis [4, 5] . Patients with RAS or BRAF wild-type CRC constitute another clinically relevant category, as these patients are the most appropriate candidates for anti-epidermal growth factor receptor (EGFR) treatment [6] . Together, these classifications highlight the complexity and heterogeneity of CRC.  \nCurrent parameters that have been implemented in guidelines mainly focus on the epithelial compartment of the tumor [7–9] . However, there is gro","cbCaiexnQwaJxL8H","https://ap.wps.com/l/cbCaiexnQwaJxL8H","pdf",1124919,16,"English","# Background\n## Colorectal cancer heterogeneity and clinical stratification\n## Tumor microenvironment and tumor-stroma role in prognosis\n## Tumor–stroma ratio and risk stratification\n## Molecular classifications and stromal biology","[{\"question\":\"Why does this review focus on the tumor stroma in colorectal cancer?\",\"answer\":\"Outcomes in advanced CRC remain poor, and evidence indicates the tumor microenvironment—particularly the tumor stroma—strongly influences prognosis and treatment response.\"},{\"question\":\"What are stromal biomarkers, and how are they clinically relevant in CRC?\",\"answer\":\"The review summarizes stromal features used as biomarkers; for example, fibroblast-associated protein (FAP) is linked to adverse outcomes, supporting clinical relevance.\"},{\"question\":\"Why have therapies targeting stromal components not worked well as single agents?\",\"answer\":\"Despite biomarker associations, therapies directly targeting stromal components have largely failed to improve survival when used alone, suggesting the need for more integrated strategies.\"}]","Therapeutic Strategies Targeting the Tumor - Stromal Microenvironment in Colorectal Cancer - A Narrative Review | PDF",1790128210,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c65b8951a291389b3c2af8b90e41b384.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abe9ce23572d3dadc2bed78c96f04f4a.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee37f6c5e19b1cb0c8e6389e81b47bcb.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00725474f66fd10794cad773efdb4c2b.webp",980,1301]